5-Part Podcast Series: Recent Clinical Updates in the Management of Multiple Sclerosis

Earn 1.25 AMA PRA Category 1 Credit(s)™, 1.25 contact hours for nursing professionals, 1.25 contact hours (.1 CEUs) for pharmacists, or 1.25 AAPA Category 1 CME credits The rapidly expanding range of disease modifying therapies (DMTs) has changed the clinical approach to the management of patients with multiple sclerosis (MS). The emergence of numerous therapeutic options …

Therapeutic Advances in the Management of Relapsing Forms of Multiple Sclerosis

Release Date: 3/12/2021 Expiration Date: 3/11/2022 Provider Statement This continuing education activity is provided by   Support Statement This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation. Target Audience The intended audience for this activity is neurologists, neurology nursing professionals, pharmacists, physician assistants, and other health care professionals involved in the management …

Initiating or Switching Therapy in Multiple Sclerosis: New Evidence and Expert Insights

*US and Canadian HCPs* Release Date: November 30, 2020 Expiration Date: November 30, 2021 Intended Audience: Physicians and their teams providing care for patients with MS (PAs, NPs, nurses, pharmacists) Accompanying this activity are resources to provide evidence-based guidance on necessary laboratory evaluations needed before initiating or switching DMTs, as well as a guide for …

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 1: Fundamentals of Cannabis

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION 1: FUNDAMENTALS OF CANNABIS RELEASE DATE: October 20, 2020 VALID FOR CREDIT THROUGH: October 31, 2021 SERIES DESCRIPTION MS health professionals may be involved in the decision-making process about cannabis and provide care to those with MS who use cannabis. However, numerous surveys indicate that …

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 2: Cannabis as an Herbal Medicine – Efficacy/Side Effect Considerations and Case Studies

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION 2: CANNABIS AS AN HERBAL MEDICINE – EFFICACY/SIDE EFFECT CONSIDERATIONS AND CASE STUDIES RELEASE DATE: October 27, 2020 VALID FOR CREDIT THROUGH: October 31, 2021 SERIES DESCRIPTION MS health professionals may be involved in the decision-making process about cannabis and provide care to those with …

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 3: Pharmacology and Interactions, Trial Data, DMTs, and Case Studies

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION 3: PHARMACOLOGY AND INTERACTIONS, TRIAL DATA, DMTs, AND CASE STUDIES RELEASE DATE: NOVEMEBER 11, 2020 VALID FOR CREDIT THROUGH: OCTOBER 31, 2021 SERIES DESCRIPTION MS health professionals may be involved in the decision-making process about cannabis and provide care to those with MS who use …

Journal Club: Monoclonal Antibody Treatment during Pregnancy and/or Lactation in Women with MS or Neuromyelitis Optica Spectrum Disorder

Release Date: September 25, 2020 Valid for Credit Through: September 30, 2021 SERIES TITLE Advanced Perspectives in MS: A Virtual Journal Club Series for the Multiple Sclerosis Clinician ARTICLE TITLE Monoclonal Antibody Treatment during Pregnancy and/or Lactation in Women with MS or Neuromyelitis Optica Spectrum Disorder TARGET AUDIENCE This activity has been designed to meet …